PKMYT1 inhibitor RP-6306 for the treatment of aberrant DNA damage repair-driven cancers March 22, 2022
Ixaka expands IP portfolio to allow use of TNP gene delivery platform across multiple areas March 21, 2022
Volastra collaborates with Bristol Myers Squibb to discover and develop oncology drug candidates March 21, 2022
RSS